EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Orbital Diffuse Large B‐Cell Lymphoma Masquerading as Periorbital Cellulitis in a Paediatric Patient With Ataxia‐Telangiectasia: A Case Report

Fajer Alabdulrazzaq, Arwa Alkanderi, Bashayer AlHazeem, Abdullah Alenezi

Case Reports in Oncological Medicine · 2026-01 · 2026 (1)

DOI: 10.1155/crom/7092035 ↗
AbstractBibliografische Angaben

Abstract

Ataxia‐telangiectasia (A‐T) is a rare autosomal recessive disorder characterised by cerebellar ataxia, combined immunodeficiency and elevated predisposition to lymphoid malignancy, rendering orbital malignancy clinically and radiologically indistinguishable from infection. We report a 7‐year‐old female with A‐T presenting with left periorbital cellulitis unresponsive to prolonged antimicrobial therapy, surgical drainage and antifungal escalation. Incisional biopsy of a persistent periorbital mass revealed diffuse large B‐cell lymphoma (DLBCL), confirmed on immunohistochemistry. Staging indicated Lugano‐modified Ann Arbour Stage IV disease, with a primary orbital mass and non‐contiguous mediastinal and abdominal disease on cross‐sectional imaging. Bone marrow assessment showed no morphological involvement, although flow cytometry detected a light chain–restricted B‐cell population. The pulmonary lesions could not be radiologically distinguished from necrotising infection. She received R‐CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone) with cyclophosphamide and vincristine reduced to approximately 50% of standard doses but died approximately 2 months after diagnosis, following a severe necrotising pulmonary infection after the second treatment cycle. This case underscores the importance of early malignancy consideration in immunocompromised A‐T patients with refractory orbital disease, the critical role of timely tissue biopsy and the diagnostic difficulty of distinguishing lymphomatous involvement from infection on imaging alone in this population.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →